遺伝子スイッチの世界市場レポート 2025年

遺伝子スイッチの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR14.1％で15億8,000万米ドルに成長します。予測期間の成長は、個別化医療に対する需要の高まり、遺伝性疾患の有病率の上昇、標的がん治療に対するニーズの高まり、世界の健康イニシアティブの高まり、遺伝子スイッチの使用の増加に起因しています。予測期間の主な動向には、技術の進歩、CRISPRベースの遺伝子スイッチ、AIの統合、遺伝子サイレンシングのための遺伝子スイッチの採用、エピジェネティック遺伝子スイッチなどがあります。

遺伝性疾患の有病率の増加は、将来の遺伝子スイッチ市場を押し上げると予測されています。遺伝性疾患は個人のDNAの異常から発生し、突然変異、遺伝的な遺伝子の変化、染色体異常などが原因となります。遺伝性疾患の増加は、認知度の向上、診断能力の強化、ヘルスケアの向上、人口の高齢化が主な原因です。遺伝子スイッチは、遺伝子発現の正確な制御を可能にすることで、これらの障害を管理する上で大きな利点を提供し、それによって標的を絞った効果的な治療法の開発を促進します。例えば、2023年9月、英国を拠点とする国立慈善団体Cystic Fibrosis Trustは、英国における嚢胞性線維症登録患者数が2021年の1万908人から2022年には1万1,148人へと240人増加したと報告しました。その結果、遺伝性疾患の発生率の増加が遺伝子スイッチ市場の成長に拍車をかけています。

個別化医療の採用拡大が遺伝子スイッチ市場の拡大を促進すると予測されます。個別化医療は、遺伝や生活習慣などの個人の特性に基づいて治療をカスタマイズし、効果を高め、副作用を軽減するものです。個別化医療の増加は、より効果的な治療の可能性、ゲノミクスの進歩、病気の複雑化、支援的な規制によって推進されています。遺伝子スイッチは、遺伝子発現を正確に制御し、個々の遺伝子プロファイルに基づいたオーダーメイドの治療アプローチを容易にすることで、個別化医療において重要な役割を果たしています。例えば、個別化医療連合（Personalized Medicine Coalition）は2024年2月、FDAが2022年の6件から2023年には16件の希少疾患に対する新しい個別化治療を承認したと報告しました。このような個別化医療の採用拡大が遺伝子スイッチ市場を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝子スイッチPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の遺伝子スイッチ市場：成長率分析
• 世界の遺伝子スイッチ市場の実績：規模と成長, 2019-2024
• 世界の遺伝子スイッチ市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝子スイッチ総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝子スイッチ市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CAR-T細胞療法
• 遺伝子治療
• その他の治療法
• 世界の遺伝子スイッチ市場採用されている支払いモデル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前払い
• マイルストーン支払い
• 世界の遺伝子スイッチ市場：応用分野別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療関連毒性の管理
• 遺伝子発現の調節
• その他の用途
• 世界の遺伝子スイッチ市場CAR T細胞療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• CD19標的CAR T細胞療法
• BCMA標的CAR T細胞療法
• CD22標的CAR T細胞療法
• 多抗原CAR-T細胞療法
• 次世代CAR-T細胞療法
• 世界の遺伝子スイッチ市場遺伝子治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アデノウイルスベクターを用いた遺伝子治療
• レンチウイルスベクターを用いた遺伝子治療
• AAV（アデノ随伴ウイルス）遺伝子治療
• CRISPR-Cas9遺伝子編集療法
• RNA干渉に基づく遺伝子治療
• 世界の遺伝子スイッチ市場その他の治療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 幹細胞療法
• RNA療法
• タンパク質補充療法
• 遺伝子編集技術
• 免疫療法のアプローチ

第7章 地域別・国別分析

• 世界の遺伝子スイッチ市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝子スイッチ市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝子スイッチ市場：競合情勢
• 遺伝子スイッチ市場：企業プロファイル
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis
  • bluebird bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Regenxbio Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Kite Pharma Inc.
• Genomatica Inc.
• Intellia Therapeutics Inc.
• Voyager Therapeutics Inc.
• Precigen Inc.
• Editas Medicine Inc.
• Cellectis SA
• Autolus Therapeutics plc
• aceRNA Technologies
• Cartherics Pty Ltd
• panCELLa Inc.
• Aptamer Group plc
• Bellicum Pharmaceuticals Inc.
• Genocea Biosciences Inc.
• CRISPR Therapeutics AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝子スイッチ市場2029：新たな機会を提供する国
• 遺伝子スイッチ市場2029：新たな機会を提供するセグメント
• 遺伝子スイッチ市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A gene switch is a molecular tool that can activate or deactivate genes or modulate their activity levels, allowing cells to adjust gene expression in response to various signals and environmental changes. Gene switches offer precise control over gene expression, facilitating targeted therapeutic treatments, advanced research endeavors, and enhanced biotechnology processes.

The primary types of gene switches include CAR T cell therapies, gene therapies, and other methods. CAR T cell therapies involve altering a patient's T cells, a type of immune cell, to express a receptor that targets cancer cells. The payment models for these therapies often include upfront payments and milestone payments, and they are used for managing treatment-related toxicity, regulating gene expression, and other therapeutic applications.

The gene switch market research report is one of a series of new reports from The Business Research Company that provides gene switch market statistics, including gene switch industry global market size, regional shares, competitors with a gene switch market share, detailed gene switch market segments, market trends, and opportunities, and any further data you may need to thrive in the gene switch industry. This gene switch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene switch market size has grown rapidly in recent years. It will grow from $0.82 $ billion in 2024 to $0.93 $ billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to the expansion of gene-based clinical trials, growth in regenerative medicine, increasing public awareness of genetic technologies, expansion of research in functional genomics, and increasing demand for genetic testing services.

The gene switch market size is expected to see rapid growth in the next few years. It will grow to $1.58 $ billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to rising demand for personalized medicine, rising prevalence of genetic disorders, rising need for targeted cancer therapies, rising global health initiatives, and increasing use of gene switches. Major trends in the forecast period include technological advancements, CRISPR-based gene switches, integration of AI, adoption of gene switches for gene silencing, and epigenetic gene switches.

The growing prevalence of genetic disorders is anticipated to boost the gene switch market in the future. Genetic disorders arise from abnormalities in an individual's DNA, which can result from mutations, inherited genetic changes, or chromosomal anomalies. This increase in genetic disorders is largely due to greater awareness, enhanced diagnostic capabilities, better healthcare, and an aging population. Gene switches offer a significant advantage in managing these disorders by allowing precise control over gene expression, thereby fostering the development of targeted and effective treatments. For instance, in September 2023, the Cystic Fibrosis Trust, a UK-based national charity, reported an increase in registered cystic fibrosis patients in the UK from 10,908 in 2021 to 11,148 in 2022, marking a rise of 240 patients. Consequently, the increasing incidence of genetic disorders is fueling growth in the gene switch market.

The growing adoption of personalized medicine is expected to drive the expansion of the gene switch market. Personalized medicine customizes medical treatments based on individual characteristics, such as genetics or lifestyle, to enhance effectiveness and reduce adverse effects. The rise in personalized medicine is propelled by its potential for more effective treatments, advances in genomics, the increasing complexity of diseases, and supportive regulations. Gene switches play a key role in personalized medicine by providing precise control over gene expression, facilitating tailored therapeutic approaches based on individual genetic profiles. For example, the Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. This growing adoption of personalized medicine is driving the gene switch market.

In January 2023, Autolus Therapeutics, a biopharmaceutical company based in the UK, partnered with Cabaletta Bio to incorporate Autolus' RQR8 safety switch system into cell therapies aimed at autoimmune diseases. This collaboration aims to enhance the safety and effectiveness of these therapies. Cabaletta Bio, a US-based biotechnology company, is involved in developing cell therapies.

Major companies operating in the gene switch market are Bristol-Myers Squibb Company, Novartis AG, Charles River Laboratories International Inc, bluebird bio Inc., Regenxbio Inc., Kite Pharma Inc., Genomatica Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., Precigen Inc., Editas Medicine Inc., Cellectis SA, Autolus Therapeutics plc, aceRNA Technologies, Cartherics Pty Ltd, panCELLa Inc., Aptamer Group plc, Bellicum Pharmaceuticals Inc., Genocea Biosciences Inc., CRISPR Therapeutics AG

North America was the largest region in the gene switch market in 2023. The regions covered in the gene switch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene switch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene switch market consists of revenues earned by entities by providing services such as gene regulation services, custom gene synthesis, research and development services, consulting, and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene switch market also includes sales of synthetic gene constructs, gene switch kits, regulatory proteins and small molecules, delivery systems, assay systems, software, and bioinformatics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Switch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene switch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene switch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene switch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: CAR T Cell Therapies; Gene Therapies; Other Therapies
• 2) By Payment Model Employed: Upfront Payments; Milestone Payments
• 3) By Application Area: Management Of Treatment Related Toxicity; Regulation Of Gene Expression; Other Applications
• Subsegments:
• 1) By CAR T Cell Therapies: CD19-Targeted CAR T Cell Therapies; BCMA-Targeted CAR T Cell Therapies; CD22-Targeted CAR T Cell Therapies; Multi-Antigen CAR T Cell Therapies; Next-Generation CAR T Cell Therapies
• 2) By Gene Therapies: Adenoviral Vector-Based Gene Therapies; Lentiviral Vector-Based Gene Therapies; AAV (Adeno-Associated Virus) Gene Therapies; CRISPR-Cas9 Gene Editing Therapies; RNA Interference-Based Gene Therapies
• 3) By Other Therapies: Stem Cell Therapies; RNA Therapy; Protein Replacement Therapy; Gene Editing Technologies; Immunotherapy Approaches
• Companies Mentioned: Bristol-Myers Squibb Company; Novartis AG; Charles River Laboratories International Inc; bluebird bio Inc.; Regenxbio Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Switch Market Characteristics

3. Gene Switch Market Trends And Strategies

4. Gene Switch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Gene Switch Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Switch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Switch Market Growth Rate Analysis
• 5.4. Global Gene Switch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Switch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Switch Total Addressable Market (TAM)

6. Gene Switch Market Segmentation

• 6.1. Global Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CAR T Cell Therapies
• Gene Therapies
• Other Therapies
• 6.2. Global Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Upfront Payments
• Milestone Payments
• 6.3. Global Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Management Of Treatment Related Toxicity
• Regulation Of Gene Expression
• Other Applications
• 6.4. Global Gene Switch Market, Sub-Segmentation Of CAR T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CD19-Targeted CAR T Cell Therapies
• BCMA-Targeted CAR T Cell Therapies
• CD22-Targeted CAR T Cell Therapies
• Multi-Antigen CAR T Cell Therapies
• Next-Generation CAR T Cell Therapies
• 6.5. Global Gene Switch Market, Sub-Segmentation Of Gene Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adenoviral Vector-Based Gene Therapies
• Lentiviral Vector-Based Gene Therapies
• AAV (Adeno-Associated Virus) Gene Therapies
• CRISPR-Cas9 Gene Editing Therapies
• RNA Interference-Based Gene Therapies
• 6.6. Global Gene Switch Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stem Cell Therapies
• RNA Therapy
• Protein Replacement Therapy
• Gene Editing Technologies
• Immunotherapy Approaches

7. Gene Switch Market Regional And Country Analysis

• 7.1. Global Gene Switch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Switch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Switch Market

• 8.1. Asia-Pacific Gene Switch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Switch Market

• 9.1. China Gene Switch Market Overview
• 9.2. China Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Switch Market

• 10.1. India Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Switch Market

• 11.1. Japan Gene Switch Market Overview
• 11.2. Japan Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Switch Market

• 12.1. Australia Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Switch Market

• 13.1. Indonesia Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Switch Market

• 14.1. South Korea Gene Switch Market Overview
• 14.2. South Korea Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Switch Market

• 15.1. Western Europe Gene Switch Market Overview
• 15.2. Western Europe Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Switch Market

• 16.1. UK Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Switch Market

• 17.1. Germany Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Switch Market

• 18.1. France Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Switch Market

• 19.1. Italy Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Switch Market

• 20.1. Spain Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Switch Market

• 21.1. Eastern Europe Gene Switch Market Overview
• 21.2. Eastern Europe Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Switch Market

• 22.1. Russia Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Switch Market

• 23.1. North America Gene Switch Market Overview
• 23.2. North America Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Switch Market

• 24.1. USA Gene Switch Market Overview
• 24.2. USA Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Switch Market

• 25.1. Canada Gene Switch Market Overview
• 25.2. Canada Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Switch Market

• 26.1. South America Gene Switch Market Overview
• 26.2. South America Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Switch Market

• 27.1. Brazil Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Switch Market

• 28.1. Middle East Gene Switch Market Overview
• 28.2. Middle East Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Switch Market

• 29.1. Africa Gene Switch Market Overview
• 29.2. Africa Gene Switch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Switch Market, Segmentation By Payment Model Employed, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Switch Market, Segmentation By Application Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Switch Market Competitive Landscape And Company Profiles

• 30.1. Gene Switch Market Competitive Landscape
• 30.2. Gene Switch Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. bluebird bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Regenxbio Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Switch Market Other Major And Innovative Companies

• 31.1. Kite Pharma Inc.
• 31.2. Genomatica Inc.
• 31.3. Intellia Therapeutics Inc.
• 31.4. Voyager Therapeutics Inc.
• 31.5. Precigen Inc.
• 31.6. Editas Medicine Inc.
• 31.7. Cellectis SA
• 31.8. Autolus Therapeutics plc
• 31.9. aceRNA Technologies
• 31.10. Cartherics Pty Ltd
• 31.11. panCELLa Inc.
• 31.12. Aptamer Group plc
• 31.13. Bellicum Pharmaceuticals Inc.
• 31.14. Genocea Biosciences Inc.
• 31.15. CRISPR Therapeutics AG

32. Global Gene Switch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Switch Market

34. Recent Developments In The Gene Switch Market

35. Gene Switch Market High Potential Countries, Segments and Strategies

• 35.1 Gene Switch Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Switch Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Switch Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer